Dr. Woodcock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of NC
#
Chapel Hill, NC 27599
Summary
- Mark Woodcock, MD, is an Oncology specialist based in Chapel Hill, NC. Having received his medical education from the University of Louisville School of Medicine in 2013, he completed his residency in Internal Medicine at the Medical College of Wisconsin Affiliated Hospitals between 2013 and 2016. Dr. Woodcock has numerous publications in high-impact journals including Nature Communications, European Urology, Journal for Immunotherapy of Cancer, and Frontiers in Oncology. His work primarily focuses on tumor responses, cancer immunotherapy, and the study of the tumor immune microenvironment. In clinic, he serves as a medical oncologist and cares for patients with sarcomas and related diseases.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 2013 - 2016
- University of Louisville School of MedicineClass of 2013
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- NC State Medical License 2016 - 2025
- WI State Medical License 2015 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- A multi-kinase inhibitor screen identifies inhibitors preserving stem-cell-like chimeric antigen receptor T cells.Feifei Song, Ourania Tsahouridis, Simone Stucchi, Tara Walhart, Sophie Mendell
Nature Immunology. 2025-02-01 - 6 citationsCTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do, Yu Qian, Xin Sun
Nature. 2024-11-01 - 1 citationsCAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanisms.Xin Zhou, Ying Wang, Zhangqi Dou, Gloria Delfanti, Ourania Tsahouridis
Nature Cancer. 2024-11-01
Press Mentions
- Former FellowsJune 20th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: